Lyophilisation Conference 2014

The global lyophilisation for pharmaceuticals products and services market will reach $3.09bn in 2014 with revenues showing strong growth to 2024. With increasing numbers of proteins being discovered, the importance of lyophilisation is coming to the fore, for example, as a means of extending the shelf life of pharmaceutical and biopharmaceutical products.

SMi is very pleased to present the 2nd annual Lyophilisation conference on 7-8 July 2014, London. This event will provide an update on methodologies for lyophilisation and examine how to mitigate risks in production. Gain practical information and tools which you can use and apply in the workplace.

Key Speakers Include
- Sune Andersen, Principal Scientist, Novo Nordisk
- Patrick Garidel, Associate Director, Protein Science, Boehringer Ingelheim
- Julie Pagenaud, Sterile Product Manufacturing Manager, Ipsen
- Massimo Rastelli, Project Leader BioPharm, GlaxoSmithKline
- Andrea Weiland, CEO, Explicat Pharma
- Mark Yang, Director of Fill Finish Development, Genzyme
- Bertie Daly, Associate Director, Alexion Pharmaceuticals
- Jamie Biddlecombe, Formulation Development Scientist, MedImmune
- Jason Gray, Consultant, Allembis (ex-Merck)
- Professor Dr Thomas de Beer, Laboratory of Process Analytical Technology, Ghent University
- Dr Rongjun Chen, Lecturer in Chemical Engineering, Imperial College London

Key Topic Insights
- Hear detailed insight into critical parameters through Lyorobustness
- Key case study from MedImmune on advancements in lyophilised drug product development and scale-up
- Discuss the costs versus benefits of optimising the lyophilisation process
- Case study from Genzyme on mitigation strategies to minimise fogging in glass vials
- Evaluate mathematical modelling in freeze drying
- Gain insight into imaging analysis as a support tool for your freeze drying cycle<